Fundraising FoxGedea Biotech
Lund, SE · 1 known investors
Find your way into Gedea Biotech
Each arrow is one introduction. Sign up to fill in the first one.
447 people can intro you to Julie
Ask Sara Lorentzon to introduce you to Julie Waras Brogren
You →Sara · together at Implexion Pharma →Julie
Sign up to find every way you can get introduced to Gedea Biotech
- Your email: who you already know at Gedea Biotech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Gedea Biotech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Gedea Biotech develops pHyph, an antibiotic-free treatment for bacterial vaginosis and other common vaginal infections aimed at supporting a healthy microbiome. A spin-out from Lund University, the company focuses on women's health and is pursuing partnerships and regulatory approvals in Europe and the US.
Founders & leadership
UE
Ulf EllervikCo-founder, board member, responsible for R&D and patents
HS
Helena StrevensCo-founder, board member, medical advisor
SM
Sophie MannerCo-founder
OS
Olov SternerCo-founder
JW
Julie Waras BrogrenCEOJulie Waras Brogren is CEO of Gedea Biotech, a women's health company developing alternatives to antibiotic treatments for bacterial vaginosis and other vaginal infections. She brings 25+ years of life science leadership experience across medical devices, diagnostics, and pharmaceuticals, with prior C-level and global committee roles at companies including Ascelia Pharma and Novo Nordisk, where she has led regulatory approvals with the EMA and FDA, managed fundraising rounds exceeding SEK 750 million, and directed commercial launches and go-to-market strategies.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountEIC Accelerator grantMar 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Gedea Biotech do?
- Gedea Biotech develops pHyph, an antibiotic-free treatment for bacterial vaginosis and other common vaginal infections aimed at supporting a healthy microbiome. A spin-out from Lund University, the company focuses on women's health and is pursuing partnerships and regulatory approvals in Europe and the US.
- Who founded Gedea Biotech?
- Gedea Biotech was founded by Ulf Ellervik, Helena Strevens, Sophie Manner, Olov Sterner.
- Who are Gedea Biotech's investors?
- Gedea Biotech's investors include LU Innovation.
- Where is Gedea Biotech headquartered?
- Gedea Biotech is headquartered in Lund, SE.